PUBLICATIONS · 25023616
Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Lymphoma Myeloma Leuk
- Publication date
- 2014 Oct
- First author
- Knopf KB
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Knopf KB
- type
- Author
- name
- Duh MS
- type
- Author
- name
- Lafeuille MH
- type
- Author
- name
- Gravel J
- type
- Author
- name
- Lefebvre P
- type
- Author
- name
- Niculescu L
- type
- Author
- name
- Ba-Mancini A
- type
- Author
- name
- Ma E
- type
- Author
- name
- Shi H
- type
- Author
- name
- Comenzo RL
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Knopf KB
- type
- Author
- name
- Duh MS
- type
- Author
- name
- Lafeuille MH
- type
- Author
- name
- Gravel J
- type
- Author
- name
- Lefebvre P
- type
- Author
- name
- Niculescu L
- type
- Author
- name
- Ba-Mancini A
- type
- Author
- name
- Ma E
- type
- Author
- name
- Shi H
- type
- Author
- name
- Comenzo RL
- type
- Author
- bibliography ids
- nci-bib-8d04036ece73c4b0320e7245
- book metadata
- content sha256
- 984c1152b523fb40128315b26fa55006c3670366a5226978a93339c54643b553
- document type
- citation
- dois
- 10.1016/j.clml.2014.03.005
- electronic publication date
- display
- 2014 Jun 11
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25023616
- immutable id
- pubmed:25023616@984c1152b523fb40128315b26fa55006c3670366a5226978a93339c54643b553
- journal
- abbreviation
- Clin Lymphoma Myeloma Leuk
- issn electronic
- 2152-2669
- issn print
- Source null
- issue
- 5
- name
- Clinical lymphoma, myeloma & leukemia
- nlm unique id
- 101525386
- pages
- 380-8
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25023616
- provenance
- batch id
- 69903be8ceab8801c81a
- provider
- NCBI PubMed ESummary
- record sha256
- 1538642e9c498673943d9009981554aa870e03cb71c09af16912bf78c867d533
- response sha256
- 1e367491c3c459a93f45b3db99ca1f9293ed2287c48bdf758bb088ffcd7c96eb
- retrieved at
- 2026-09-09T23:47:05.208886+00:00
- publication date
- display
- 2014 Oct
- precision
- month
- year
- 2014
- publication types
- Journal Article
- Meta-Analysis
- Research Support, Non-U.S. Gov't
- Systematic Review
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myeloma.
Preserved source evidence · Not medical advice
Triangle